These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37736055)

  • 1. Associated Factors of Tophaceous Gout: A Study Involving 20 Primary Care Clinics in an Urbanized State in Malaysia.
    Gan SP; Zain MM; Ch'ng SS; Hassan H; Wan Adib WF; Muzaid A; Lau IS; Yusoof H; Rosman A; Baharuddin H
    Oman Med J; 2023 Jul; 38(4):e528. PubMed ID: 37736055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
    Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
    J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe tophaceous gout. Characterization of low socioeconomic level patients from México.
    Vázquez-Mellado J; Cruz J; Guzmán S; Casasola-Vargas J; Lino L; Burgos-Vargas R
    Clin Exp Rheumatol; 2006; 24(3):233-8. PubMed ID: 16870088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Cutaneous Presentation of Chronic Tophaceous Gout: A Case Report.
    Pradhan S; Sinha R; Sharma P; Sinha U
    Indian Dermatol Online J; 2020; 11(2):235-238. PubMed ID: 32477988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic tophaceous gout with unusual large tophi: case report.
    Aradoini N; Talbi S; Berrada K; Abourazzak FZ; Harzy T
    Pan Afr Med J; 2015; 22():132. PubMed ID: 26889313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of ultrasound-detected tophi in patients with gout.
    Lu B; Lu Q; Huang B; Li C; Zheng F; Wang P
    Clin Rheumatol; 2020 Jun; 39(6):1953-1960. PubMed ID: 32062769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of indications, results and complications of surgery for tophaceous gout.
    Kumar S; Gow P
    N Z Med J; 2002 Jul; 115(1158):U109. PubMed ID: 12362184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study.
    Rajan A; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM; Dalbeth N
    Arthritis Res Ther; 2013 Oct; 15(5):R160. PubMed ID: 24286500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcerated Tophaceous Gout.
    Zahoor H; Patel R; El-Bahri J
    Cureus; 2022 Sep; 14(9):e28729. PubMed ID: 36204027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
    Dalbeth N; Jones G; Terkeltaub R; Khanna D; Kopicko J; Bhakta N; Adler S; Fung M; Storgard C; Baumgartner S; Perez-Ruiz F
    Arthritis Rheumatol; 2017 Sep; 69(9):1903-1913. PubMed ID: 28597604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-specific association between ABCG2 variants and tophaceous disease in people with gout.
    He W; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2017 Mar; 19(1):43. PubMed ID: 28270222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tophaceous gout: When medication is not enough.
    Kasper IR; Juriga MD; Giurini JM; Shmerling RH
    Semin Arthritis Rheum; 2016 Jun; 45(6):669-74. PubMed ID: 26947439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INCREASED RISK OF COLORECTAL CANCER IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT: A POPULATION-BASED STUDY.
    Boustany A; Rahhal R; Mitri J; Onwuzo S; Zeid HKA; Asaad I
    Arq Gastroenterol; 2023; 60(3):339-344. PubMed ID: 37792763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between fat, muscle, bone mass, and oteophytes and risk for tophaceous gout.
    Hsu CM; Hsu CC; Wu RW; Huang CC; Chen YC
    J Investig Med; 2023 Jan; 71(1):58-61. PubMed ID: 36316064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Tophaceous Gout Presenting as Bilateral Knee Masses in an Adult Patient: A Case Report.
    Patel UJ; Freetly TJ; Yueh J; Campbell C; Kelly MA
    J Orthop Case Rep; 2019; 9(5):16-19. PubMed ID: 32547995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
    Baraf HS; Becker MA; Gutierrez-Urena SR; Treadwell EL; Vazquez-Mellado J; Rehrig CD; Ottery FD; Sundy JS; Yood RA
    Arthritis Res Ther; 2013 Sep; 15(5):R137. PubMed ID: 24286509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tophi reduction: ultrasound imaging and correlation with plasma levels of uric acid in patients undergoing treatment for tophaceous gout.
    Ferrari AJL; Corrêa Fernandes AR; De Almeida Agustinelli R; Seike H; De Ávila Fernandes E
    Reumatismo; 2019 Jul; 71(2):75-80. PubMed ID: 31309777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.